Log in

CVE:CZOCeapro Stock Price, Forecast & News

C$0.41
-0.01 (-2.38 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.41
Now: C$0.41
C$0.44
50-Day Range
C$0.23
MA: C$0.28
C$0.44
52-Week Range
C$0.14
Now: C$0.41
C$0.45
Volume56,500 shs
Average Volume73,837 shs
Market CapitalizationC$31.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ceapro Inc., a biotechnology company, engages in developing and commercializing functionally active ingredients in the United States, Canada, Germany, China, and internationally. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, including Pressurized Gas eXpanded drying technology; new oat variety and technologies to enhance the content of avenanthramides; and CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4214555

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$12.88 million
Cash FlowC$0.04 per share
Book ValueC$0.29 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$31.71 million
Next Earnings Date8/26/2020 (Estimated)
OptionableNot Optionable

Receive CZO News and Ratings via Email

Sign-up to receive the latest news and ratings for CZO and its competitors with MarketBeat's FREE daily newsletter.

Ceapro (CVE:CZO) Frequently Asked Questions

How has Ceapro's stock been impacted by COVID-19 (Coronavirus)?

Ceapro's stock was trading at C$0.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CZO stock has increased by 86.4% and is now trading at C$0.41. View which stocks have been most impacted by Coronavirus.

When is Ceapro's next earnings date?

Ceapro is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Ceapro.

Has Ceapro been receiving favorable news coverage?

Media stories about CZO stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ceapro earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news aboutCeapro.

Who are some of Ceapro's key competitors?

What other stocks do shareholders of Ceapro own?

Who are Ceapro's key executives?

Ceapro's management team includes the following people:
  • Mr. Gilles R. Gagnon M.B.A., M.Sc., MBA, ICD.D, CEO, Pres & Director (Age 65)
  • Ms. Stacy Prefontaine CPA, CA, CFO & Corp. Sec.

What is Ceapro's stock symbol?

Ceapro trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CZO."

How do I buy shares of Ceapro?

Shares of CZO and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Ceapro's stock price today?

One share of CZO stock can currently be purchased for approximately C$0.41.

How big of a company is Ceapro?

Ceapro has a market capitalization of C$31.71 million and generates C$12.88 million in revenue each year.

What is Ceapro's official website?

The official website for Ceapro is www.ceapro.com.

How can I contact Ceapro?

Ceapro's mailing address is 7824 51 Ave NW, EDMONTON, AB T6E 6W2, Canada. The company can be reached via phone at +1-780-4214555.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.